Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2003

View Archived Issues

Three series of COX-2 inhibitors prepared and tested at GSK

Protection of heart allografts by alpha-MSH in rats

Potential use of early kidney precursors in renal transplantation

Sex differences for NO-induced effects in sickle cell disease

Hemoglobin raffimer in coronary artery bypass graft surgery

Lipid-lowering effects reported for a diet combining soy proteins, plant sterols and viscous fiber

New antitumor agents prepared and tested by French team

Boehringer Ingelheim claims new telomerase inhibitors

Wyeth presents new beta-lactamase inhibitors in recent patent

Orally available carbapenem antibiotics in early development at Kyoto Pharmaceutical

Banyu scientists prepare and test piperidine-based NPY antagonists

New series of antibacterial compounds discovered by Washington U. scientists

CAT and Dyax expand licensing agreement

ABI-007 receives fast track status for metastatic breast cancer

Galenica and Spanish National Center of Biotechnology to develop smallpox subunit vaccine

Novartis and Ivax sign Airmax inhaler agreement for respiratory products

Novartis seeks approval for lower dose of Estalis in Sweden

Ono and GSK sign agreement for Ono-4128

Zavesca marketing approval sought in Israel

Ranexa terminates ventricular tachycardia in preclinical study

Positive phase III results for Enbrel in psoriasis

New title added to the Drug R&D Backgrounders topic list - Bipolar Disorder

Vascular targeting agent ZD-6126 exerts significant antitumor activity at well-tolerated doses

Chiesi's budesonide Modulite pMDI approved in Germany

Biprel launched in Canada for hypertension

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...